cytovale Cytovale’s Rapid Diagnostic Slashes Sepsis Mortality by 39%, Peer-Reviewed Study Confirms BioSpace 2025.06.13
cytovale Accelerated Demand for Cytovale’s FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025 PR Newswire 2025.01.09
cytovale Cytovale Recognized as One of Modern Healthcare’s 2024 Best in Business PR Newswire 2024.12.09
cytovale Cytovale’s FDA-Cleared Sepsis Diagnostic Triages First 5,000 Patients, Paves Way to New Hospital Protocols for Sepsis Management BioSpace 2024.06.20
cytovale Cytovale’s sepsis diagnostic test demonstrates 97.5% NPV in latest study ClinicalTrials Arena 2024.05.03
cytovale Cytovale’s Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application PR Newswire 2024.03.19
cytovale BARDA announces clinical studies of host-based diagnostics to demonstrate impact in improving patient care Medical Countermeasures.gov 2024.02.06
cytovale New Study Underscores Need for Greater Objectivity and Speed in Sepsis Diagnosis and Triage PR Newswire 2023.12.06
cytovale Cytovale collects $84M to roll out its rapid ER sepsis diagnostic test FIERCE Biotech 2023.11.16
cytovale IntelliSep Sepsis Test Could Save Money and Patient Lives INSIDE PRECISION MEDICINE 2023.09.27
cytovale Cytovale Strengthens Leadership Team With Appointment Of Dr. Robert Scoggins As Inaugural Chief Medical Officer HEALTHCARE BUSINESS TODAY 2023.07.23
cytovale A Chat with Professor Michael Atar, Scientific Advisor And Lead Investor in Cytovale TechRound 2023.06.23
cytovale Late-Breaking Data for Cytovale’s IntelliSep® Sepsis Test Further Validate its Potential to Aid in Rapid, Clinically Actionable Sepsis Diagnosis in Emergency Departments yahoo!finance 2023.05.23
cytovale FDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools businesswire 2023.01.18
cytovale Cytovale Reveals 10-Minute, 510(k) Pending Cytovale System and IntelliSep Test for Sepsis at AACC 2022 businesswire 2022.07.25
cytovale Cytovale™ IntelliSep™ Test Demonstrates Potential to Rapidly Risk-Stratify Suspected COVID-19 Patients in New Study yahoo!finance 2022.03.17
